Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-03-05Clinical Trial Update: AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC [Phase 2]
Phase 2 clinical trial update on AK112 as neoadjuvant/adjuvant therapy for resectable non-small cell lung cancer; the study is currently act…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
A multicenter observational prospective study in advanced non-small cell lung cancer to determine the incidence of HER2 mutations and assess…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating STRO-004 in adults with refractory or recurrent metastatic cancer is currently recruiting, investigating…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ [Phase 3]
A Phase 3 clinical trial comparing SYS6010 to Docetaxel for previously treated EGFR wild-type non-small cell lung cancer; the study is not y…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients [Phase 2]
Phase 2 trial in Non-Small Cell Lung Cancer investigating tumor microenvironment and optimal duration of immunotherapy has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Phase 3 Clinical Study of AK112 for NSCLC Patients [Phase 3]
Phase 3 trial update for AK112 in non-small cell lung cancer; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 trial evaluating selpercatinib as adjuvant therapy after surgery or radiation in patients with non-small cell lung cancer; the stu…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation [Phase 2]
Phase 2 clinical trial protocol evaluating pneumonitis prevention using pentoxifylline and alpha-tocopherol in stage III non-small cell lung…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI) [Phase 2]
Phase 2 clinical trial evaluating a ctDNA-guided CURB strategy for oligo-progressive metastatic non-small cell lung cancer in patients on ty…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy [Phase 2]
A Phase 2 trial is evaluating durvalumab in combination with radiation therapy for early-stage non-small cell lung cancer. The study is curr…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC) [Phase 2]
This is an update on a Phase 2 trial evaluating five years of adjuvant osimertinib in completely resected EGFR-mutant non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
The document notes a completed observational clinical trial involving patients with palliative, asymptomatic, centrally located advanced non…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 [Phase 2]
A Phase 2 clinical trial is evaluating perioperative cemiplimab for patients with resectable non-small cell lung cancer and high PD-L1 expre…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of osimertinib and carotuximab in advanced EGFR-mutated non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: 18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC
This entry reports an active but not recruiting clinical trial evaluating 18F-FDG PET/CT radiomics for precision diagnosis and prognosis in …
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Palliative Thoracic ImmunoRT
Clinical trial update for the Palliative Thoracic ImmunoRT study indicates the trial in non-small cell lung cancer is currently active but n…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC) [Phase 2]
A Phase 2 trial evaluating SHR-1210 in combination with apatinib in advanced non-small cell lung cancer has completed and posted results.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC [Phase 1, Phase 2]
First-in-human Phase 1/2 trial of the NaPi2b-targeted antibody-drug conjugate TUB-040 assessing safety, PK, and preliminary efficacy in pati…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 3 Study of IN10018 in Combination With D-1553 Versus Standard Therapy for First Line Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation [Phase 3]
A Phase 3 clinical trial is evaluating IN10018 in combination with D-1553 versus standard therapy as first-line treatment for non-squamous n…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: LM103 in Phase IIa Clinical Trial for Adjuvant Treatment in Patients With Non-small Cell Lung Cancer [Phase 2]
A Phase IIa adjuvant trial of LM103 for non-small cell lung cancer is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities [Phase 1, Phase 2]
A Phase 1/2 clinical trial of TAS0953/HM06, a RET inhibitor, in adults with RET-altered advanced solid tumors including non-small cell lung …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
A clinical trial update describing a prospective external control cohort in newly diagnosed advanced or metastatic EGFR-mutant non-small cel…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: First in Human Study of TUB-030 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
First-in-human study of TUB-030 is underway in patients with advanced solid tumors, including head and neck squamous cell carcinoma, small c…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of Oral MRT-2359 in Selected Cancer Patients [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 trial evaluating MRT-2359 in multiple cancer indications; trial is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
This entry reports the OSIREAL real-world evidence trial of Osimertinib for EGFR-mutant non-small cell lung cancer in Spain, sponsored by As…